Etretinate

Etretinate is a lipid of Prenol Lipids (PR) class. Etretinate is associated with abnormalities such as Psoriasis, Skin lesion, Scleroderma, Chronic graft-versus-host disease and Evaluable Disease. The involved functions are known as Agent, Ulcer and Teratogenesis. Etretinate often locates in Hepatic and Skin. The related lipids are Steroids and Steroid, Systemic.

Cross Reference

Introduction

To understand associated biological information of Etretinate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Etretinate?

Etretinate is suspected in Scleroderma, Chronic graft-versus-host disease, Psoriasis, Skin lesion, Evaluable Disease, Pneumonia, Bacterial and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

No disease MeSH terms mapped to the current reference collection.

PubChem Associated disorders and diseases

What pathways are associated with Etretinate

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Etretinate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Etretinate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Etretinate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Etretinate?

There are no associated biomedical information in the current reference collection.

What common seen animal models are associated with Etretinate?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Etretinate

Download all related citations
Per page 10 20 50 100 | Total 1071
Authors Title Published Journal PubMed Link
Hersle K et al. Severe oral lichen planus: treatment with an aromatic retinoid (etretinate). 1982 Br. J. Dermatol. pmid:7037037
Yoshiike T et al. Biochemical changes after the oral administration of retinoid in the horny layer of patients with keratinization disorders. 1982 J. Dermatol. pmid:6752237
Sakamoto K et al. Influence of etretinate on blood and liver in rats. 1982 Jpn. J. Pharmacol. pmid:7161968
Kanerva L et al. Light and electron microscopy of psoriatic skin before and during retinoid (Ro 10-9359) and retinoid-PUVA treatment. 1982 J. Cutan. Pathol. pmid:7130503
Ehmann CW and Voorhees JJ International studies of the efficacy of etretinate in the treatment of psoriasis. 1982 J. Am. Acad. Dermatol. pmid:7040512
Gomez EC Actions of isotretinoin and etretinate on the pilosebaceous unit. 1982 J. Am. Acad. Dermatol. pmid:6950956
Brazzell RK and Colburn WA Pharmacokinetics of the retinoids isotretinoin and etretinate. A comparative review. 1982 J. Am. Acad. Dermatol. pmid:6461675
Goldstein JA et al. Comparative effect of isotretinoin and etretinate on acne and sebaceous gland secretion. 1982 J. Am. Acad. Dermatol. pmid:6461679
Moriarty M et al. Etretinate in treatment of actinic keratosis. A double-blind crossover study. 1982 Lancet pmid:6120350
Yamakage A and Ishikawa H [Alterations of serum lipids in patients with psoriasis vulgaris after retinoid administration]. 1982 Nihon Hifuka Gakkai Zasshi pmid:6985291
Bichler E and Daxenbichler G Retinoic acid-binding protein in human squamous cell carcinomas of the ORL region. 1982 Cancer pmid:7055776
Claudy AL et al. Epidermodysplasia verruciformis induced by a new human papillomavirus (HPV-8). Report of a case without immune dysfunction. Effect of treatment with an aromatic retinoid. 1982 Arch. Dermatol. Res. pmid:6299205
McGuire J et al. The influence of retinoids on cultivated human keratinocytes. 1982 J. Am. Acad. Dermatol. pmid:6175669
Rustin GJ and Bagshawe KD Trial of an aromatic retinoid in patients with solid tumours. 1982 Br. J. Cancer pmid:7059478
Ellis CN et al. Etretinate therapy stimulates deposition of mucus-like material in epidermis of patients with psoriasis. 1982 J. Am. Acad. Dermatol. pmid:7068978
Mom A et al. Razoxane in the treatment of psoriatic patients resistant to or intolerant of PUVA, methotrexate and etretinate. 1982 Acta Derm. Venereol. pmid:6183878
Short clinical reports: serum lipid changes during etretinate therapy. 1982 J. Am. Acad. Dermatol. pmid:7068979
Yoshiike T et al. [Cases of Vörner type congenital palmo-plantar keratosis in a father and daughter: biochemical analysis of the stratum corneum and the effect of retinoid administration]. 1982 Nihon Hifuka Gakkai Zasshi pmid:6184505
Wishart J Successful treatment of conglobate acne using oral retinoid Ro-10-9359. 1982 Australas. J. Dermatol. pmid:6215022
Yui Y [A toxicological study of etretinate and its effect on blood and tissue (author's transl)]. 1982 J Toxicol Sci pmid:7097811
van der Schroeff JG et al. Epidermal Langerhans cells in erythrokeratodermia variabilis. Histochemical and ultrastructural investigations before and after treatment with etretinate (RO 10-9359). 1982 Arch. Dermatol. Res. pmid:6187301
Lindskov R Soft nails after treatment with aromatic retinoids. 1982 Arch Dermatol pmid:7103518
Ellis CN et al. Etretinate therapy causes increases in lipid levels in patients with psoriasis. 1982 Arch Dermatol pmid:7103524
Gutschmidt S and Tsambaos D Effect of large doses of etretinate (Tigason) on enzymes of the rat kidney. 1982 Br. J. Dermatol. pmid:7104220
Yokoyama M et al. Necessity of bile for and lack of inhibitory effect of retinoid on development of forestomach papillomas in nontreated mutant mice of the W/Wv genotype. 1982 Cancer Res. pmid:7105046
Dubertret L et al. Inhibition of neutrophil migration by etretinate and its main metabolite. 1982 Br. J. Dermatol. pmid:6216907
Vanderveen EE et al. Methotrexate and etretinate as concurrent therapies in severe psoriasis. 1982 Arch Dermatol pmid:7114868
Windhorst DB and Nigra T General clinical toxicology of oral retinoids. 1982 J. Am. Acad. Dermatol. pmid:6950955
Gilardi S and Schibli H [Therapeutic possibilities in ichthyosis and ichthyosiforme states]. 1982 Rev Med Suisse Romande pmid:7178733
Cowart VS Etretinate therapy improves psoriasis but elevates serum lipids. 1982 JAMA pmid:7077753
Gouveia J et al. Degree of bronchial metaplasia in heavy smokers and its regression after treatment with a retinoid. 1982 Lancet pmid:6122008
Salamon T et al. [Meleda disease - akroerythrokeratoderma]. 1982 Z. Hautkr. pmid:6211845
Driban NE and Jung JR Papillon-Lefèvre syndrome. A clinical and therapeutical contribution. 1982 Dermatologica pmid:6220930
Nemanic MK et al. Perturbations of membrane glycosylation in retinoid-treated epidermis. 1982 J. Am. Acad. Dermatol. pmid:6175671
Forte M [Clinical experience with Tigason 10 mg]. 1982 Jul-Aug G Ital Dermatol Venereol pmid:6227553
Graifemberghi S et al. [Lewandosky-Lutz verruciformis epidermodysplasia. Immunologic study and treatment with the aromatic retinoid Ro 10-9359]. 1982 May-Jun G Ital Dermatol Venereol pmid:7187403
Nolibe D et al. Effect of chronic administration of a synthetic aromatic retinoid (Ro 10-9359) on the development of lung squamous metaplasia and epidermoid cancer in rats. 1983 Adv. Exp. Med. Biol. pmid:6650282
Kumar R et al. Erythrocyte membrane phosphorylation in untreated and in etretinate-treated psoriatic patients. 1983 Br. J. Dermatol. pmid:6615715
Jensen JR et al. Etretinate therapy and immune reactivity. 1983 Arch. Dermatol. Res. pmid:6625655
Tamayo L Monilethrix treated with the oral retinoid Ro 10-9359 (Tigason). 1983 Clin. Exp. Dermatol. pmid:6627730
Lorand T et al. Treatment of generalized pustular psoriasis with Ro-10-9359. 1983 Dermatologica pmid:6628814
Paravicini U and Busslinger A Determination of etretinate and its main metabolite in human plasma using normal-phase high-performance liquid chromatography. 1983 J. Chromatogr. pmid:6630385
Ishizaki H et al. Serum levels of Etretinate (Ro 10-9359) and its metabolite (Ro 10-1670). 1983 J. Dermatol. pmid:6230381
Dupré A et al. [Constitutional painful callosities. Analgesic efficacy of etretinate]. 1983 Ann Dermatol Venereol pmid:6230038
Adams JD Concurrent methotrexate and etretinate therapy for psoriasis. 1983 Arch Dermatol pmid:6614945
Kanerva L et al. Electron microscopic observations of mitotic Langerhans' cells as possible sign of retinoid-induced stimulation. 1983 J. Cutan. Pathol. pmid:6853796
Altmeyer P et al. Morphological and functional findings of fixed phagocytes in psoriatics. 1983 Arch. Dermatol. Res. pmid:6870349
Rabinovitz HS et al. Response of psoriatic nails to the aromatic retinoid etretinate. 1983 Arch Dermatol pmid:6870312
Solano E and Hidalgo H [Dermatoses difficult to treat. Their treatment with an aromatic retinoid (etretinate)]. 1983 Med Cutan Ibero Lat Am pmid:6230492
Rollman O and Vahlquist A Retinoid concentrations in skin, serum and adipose tissue of patients treated with etretinate. 1983 Br. J. Dermatol. pmid:6226308